← SearchINSILICO AND EX-VIVO IMMUNOGENICITY ANALYSIS OF NCATS GENE THERAPY TEST$564,711N01FY2024CANIHLeidos Biomedical Research, Inc., Frederick MDInvestigatorsMax MoorecontactView original record on NIH RePORTER →